SEC 13F Intelligence

Mpm Bioimpact LLC / CYTK

Mpm Bioimpact LLC’s Cytokinetics Inc Position

Does Mpm Bioimpact LLC own Cytokinetics Inc (CYTK)? Yes — 500.0K shares worth $33M (+2.54% of its 13F portfolio) as of Q1 2026, up from 193.2K shares the prior filed quarter.

Position Value
$33M
Q1 2026
Shares
500.0K
% of Portfolio
+2.54%
Quarters Held
6
currently held

Position History CYTK

Reported value by quarter
Q3 ’21: $9MQ3 ’21Q4 ’21: $11MQ4 ’21Q1 ’22: $8MQ1 ’22Q2 ’22: $8MQ2 ’22Q3 ’22: $9MQ3 ’22Q1 ’26: $33MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026500.0K$33M+2.54%
Q3 2022193.2K$9M+2.22%
Q2 2022194.2K$8M+2.12%
Q1 2022224.2K$8M+2.22%
Q4 2021232.3K$11M+1.93%
Q3 2021247.3K$9M+1.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of CYTK.